Cambient Family Office’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cambient Family Office's BMY Position: Q2 2026 in Review
Cambient Family Office increased its Bristol-Myers Squibb (BMY) stake by 21% in Q2 2026, buying an estimated $80.7K and bringing the position to 8,131 shares worth $468K. The position accounts for 0.06% of the portfolio, ranked #155.
Cambient Family Office first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Cambient Family Office held 8,131 shares of Bristol-Myers Squibb worth $468K as of Q2 2026.
- Cambient Family Office bought 1,405 Bristol-Myers Squibb shares in Q2 2026, an estimated $80.7K.
- Bristol-Myers Squibb made up 0.06% of Cambient Family Office's portfolio in Q2 2026, its #155 holding.
- Cambient Family Office first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Cambient Family Office's 13F filing for Q2 2026, filed 13 Aug 2026.